Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
VITTORIO SCAGLIOTTI, Giorgio, PARIKH, Purvish, LEE, Jin S, MELLEMGAARD, Anders, PARK, Keunchil, PATIL, Shehkar, ROLSKI, Janusz, GOKSEL, Tuncay, DE MARINIS, Filippo, SIMMS, Lorinda, SUGARMAN, Katherine P, GANDARA, David, VON PAWEL, Joachim, BIESMA, Bonne, VANSTEENKISTE, Johan, MANEGOLD, Christian, SERWATOWSKI, Piotr, GATZEMEIER, Ulrich, DIGUMARTI, Raghunadharao, ZUKIN, Mauro
Published in Journal of clinical oncology (20.07.2008)
Published in Journal of clinical oncology (20.07.2008)
Get full text
Journal Article
Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST Study
ROBERTSON, John F. R, LLOMBART-CUSSAC, Antonio, ROLSKI, Janusz, FELTL, David, DEWAR, John, MACPHERSON, Euan, LINDEMANN, Justin, ELLIS, Matthew J
Published in Journal of clinical oncology (20.09.2009)
Published in Journal of clinical oncology (20.09.2009)
Get full text
Journal Article
Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
Monk, Bradley J, Herzog, Thomas J, Kaye, Stanley B, Krasner, Carolyn N, Vermorken, Jan B, Muggia, Franco M, Pujade-Lauraine, Eric, Lisyanskaya, Alla S, Makhson, Anatoly N, Rolski, Janusz, Gorbounova, Vera A, Ghatage, Prafull, Bidzinski, Mariusz, Shen, Keng, Ngan, Hextan Yuen-Sheung, Vergote, Ignace B, Nam, Joo-Hyun, Park, Youn Choi, Lebedinsky, Claudia A, Poveda, Andrés M
Published in Journal of clinical oncology (01.07.2010)
Published in Journal of clinical oncology (01.07.2010)
Get full text
Journal Article
Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens
VALERO, Vicente, FORBES, John, FUMOLEAU, Pierre, ROLSKI, Janusz, MRSIC-KRMPOTIC, Zrinka, JAGIELLO-GRUSZFELD, Agnieszka, RIVA, Alessandro, BUYSE, Marc, TAUPIN, Henry, SAUTER, Guido, PRESS, Michael F, SLAMON, Dennis J, PEGRAM, Mark D, PIENKOWSKI, Tadeusz, EIERMANN, Wolfgang, VON MINCKWITZ, Gunter, ROCHE, Henri, MARTIN, Miguel, CROWN, John, MACKEY, John R
Published in Journal of clinical oncology (10.01.2011)
Published in Journal of clinical oncology (10.01.2011)
Get full text
Journal Article
Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment
ALBAIN, Kathy S, NAG, Shona M, SIMMS, Lorinda, O'SHAUGHNESSY, Joyce, CALDERILLO-RUIZ, German, JORDAAN, Johann P, LLOMBART, Antonio C, PLUZANSKA, Anna, ROLSKI, Janusz, MELEMED, Allen S, REYES-VIDAL, Jose M, SEKHON, Jagdev S
Published in Journal of clinical oncology (20.08.2008)
Published in Journal of clinical oncology (20.08.2008)
Get full text
Journal Article
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
Mackey, John R, Prof, Martin, Miguel, Prof, Pienkowski, Tadeusz, Prof, Rolski, Janusz, MD, Guastalla, Jean-Paul, MD, Sami, Amer, MD, Glaspy, John, MD, Juhos, Eva, MD, Wardley, Andrew, MD, Fornander, Tommy, MD, Hainsworth, John, MD, Coleman, Robert, MD, Modiano, Manuel R, MD, Vinholes, Jeferson, MD, Pinter, Tamas, MD, Rodríguez-Lescure, Álvaro, MD, Colwell, Bruce, MD, Whitlock, Pierre, MD, Provencher, Louise, MD, Laing, Kara, MD, Walde, David, MD, Price, Chris, MD, Hugh, Judith C, MD, Childs, Barrett H, MD, Bassi, Kimberly, BS, Lindsay, Mary-Ann, PharmD, Wilson, Véronique, MSc, Rupin, Matthieu, MSc, Houé, Vincent, MSc, Vogel, Charles, MD
Published in The lancet oncology (2013)
Published in The lancet oncology (2013)
Get full text
Journal Article
Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial
Grunberg, Steven M, Prof, Rolski, Janusz, MD, Strausz, Janos, MD, Aziz, Zeba, Prof, Lane, Stephen, MSc, Russo, Mark W, MD, Wissel, Paul, MD, Guckert, Mary, RN MSN, Wright, Oliver, MD, Herrstedt, Jørn, Prof
Published in The lancet oncology (01.06.2009)
Published in The lancet oncology (01.06.2009)
Get full text
Journal Article
Real-world treatment practice in patients with advanced melanoma
Cybulska-Stopa, Bożena, Piejko, Karolina, Pacholczak, Renata, Domagała-Haduch, Małgorzata, Drosik-Kwaśniewska, Anna, Rolski, Janusz, Wiktor-Mucha, Patrycja, Zemełka, Tomasz
Published in Contemporary oncology (Poznan, Poland) (01.01.2020)
Published in Contemporary oncology (Poznan, Poland) (01.01.2020)
Get full text
Journal Article
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer
Scagliotti, Giorgio Vittorio, Parikh, Purvish, von Pawel, Joachim, Biesma, Bonne, Vansteenkiste, Johan, Manegold, Christian, Serwatowski, Piotr, Gatzemeier, Ulrich, Digumarti, Raghunadharao, Zukin, Mauro, Lee, Jin S, Mellemgaard, Anders, Park, Keunchil, Patil, Shehkar, Rolski, Janusz, Goksel, Tuncay, de Marinis, Filippo, Simms, Lorinda, Sugarman, Katherine P, Gandara, David
Published in Journal of clinical oncology (10.05.2023)
Published in Journal of clinical oncology (10.05.2023)
Get full text
Journal Article
A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer
Ramlau, Rodryg, Quoix, Elisabeth, Rolski, Janusz, Pless, Miklos, Lena, Herve, Lévy, Eric, Krzakowski, Maciej, Hess, Dagmar, Tartour, Eric, Chenard, Marie-Pierre, Limacher, Jean-Marc, Bizouarne, Nadine, Acres, Bruce, Halluard, Céline, Velu, Thierry
Published in Journal of thoracic oncology (01.07.2008)
Published in Journal of thoracic oncology (01.07.2008)
Get full text
Journal Article
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
Pritchard, Kathleen I, Rolski, Janusz, Papai, Zsuzsanna, Mauriac, Louis, Cardoso, Fatima, Chang, Jose, Panasci, Lawrence, Ianuli, Carmen, Kahan, Zsuzsanna, Fukase, Kenjiro, Lindemann, Justin P. O, Macpherson, Merran P, Neven, Patrick
Published in Breast cancer research and treatment (01.09.2010)
Published in Breast cancer research and treatment (01.09.2010)
Get full text
Journal Article
First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland
Cybulska-Stopa, Bożena, Pacholczak-Madej, Renata, Kamińska-Winciorek, Grażyna, Ziętek, Marcin, Czarnecka, Anna M, Piejko, Karolina, Galus, Łukasz, Ziółkowska, Barbara, Kieszko, Stanisław, Kempa-Kamińska, Natasza, Calik, Jacek, Rolski, Janusz, Sałek-Zań, Agata, Gajewska-Wicher, Katarzyna, Drosik-Kwaśniewska, Anna, Rogala, Paweł, Kubiatowski, Tomasz, Suwiński, Rafał, Mackiewicz, Jacek, Rutkowski, Piotr
Published in Immunotherapy (01.03.2021)
Published in Immunotherapy (01.03.2021)
Get full text
Journal Article
Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study
Martin, Miguel, Prof, Roche, Henri, Prof, Pinter, Tamas, MD, Crown, John, Prof, Kennedy, M John, MB, Provencher, Louise, MD, Priou, Frank, MD, Eiermann, Wolfgang, Prof, Adrover, Encarna, MD, Lang, Istvan, Prof, Ramos, Manuel, MD, Latreille, Jean, FRCPC, Jagiełło-Gruszfeld, Agnieszka, MD, Pienkowski, Tadeusz, MD, Alba, Emilio, MD, Snyder, Raymond, MMed, Almel, Sachin, MD, Rolski, Janusz, MD, Munoz, Montserrat, MD, Moroose, Rebecca, MD, Hurvitz, Sara, MD, Baños, Ana, BSc, Adewoye, Henry, MD, Hei, Yong-Jiang, MD, Lindsay, Mary-Ann, PhD, Rupin, Matthieu, MSc, Cabaribere, David, MSc, Lemmerick, Yasmin, MBA, Mackey, John R, Prof
Published in The lancet oncology (01.04.2011)
Published in The lancet oncology (01.04.2011)
Get full text
Journal Article
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study
Robertson, John F. R., Lindemann, Justin P. O., Llombart-Cussac, Antonio, Rolski, Janusz, Feltl, David, Dewar, John, Emerson, Laura, Dean, Andrew, Ellis, Matthew J.
Published in Breast cancer research and treatment (01.11.2012)
Published in Breast cancer research and treatment (01.11.2012)
Get full text
Journal Article
Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study
Scagliotti, Giorgio V, Park, Keunchil, Patil, Shekar, Rolski, Janusz, Goksel, Tuncay, Martins, Renato, Gans, Steven J.M, Visseren-Grul, Carla, Peterson, Patrick
Published in European journal of cancer (1990) (01.09.2009)
Published in European journal of cancer (1990) (01.09.2009)
Get full text
Journal Article
Immunotherapy or targeted therapy as first-line treatment of patients with advanced/metastatic melanoma with the BRAF mutation — a single-center analysis
Cybulska-Stopa, Bożena, Piejko, Karolina, Pacholczak, Renata, Domagała-Haduch, Małgorzata, Drosik-Kwaśniewska, Anna, Sałek-Zań, Agata, Wiktor-Mucha, Patrycja, Rolski, Janusz, Zemełka, Tomasz
Published in Oncology in Clinical Practice (17.08.2020)
Published in Oncology in Clinical Practice (17.08.2020)
Get full text
Journal Article
Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes
Jones, Alison, O'Brien, Mary, Sommer, Harald, Nowara, Elzbieta, Welt, Anja, Pienkowski, Tadeusz, Rolski, Janusz, Pham, My-Linh, Perraud, Kevin, Trillet-Lenoir, Véronique
Published in Cancer chemotherapy and pharmacology (01.03.2010)
Published in Cancer chemotherapy and pharmacology (01.03.2010)
Get full text
Journal Article
Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaieve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study
Scagliotti, Giorgio V, Park, Keunchil, Patil, Shekar, Rolski, Janusz, Goksel, Tuncay, Martins, Renato, Gans, Steven JM, Visseren-Grul, Carla, Peterson, Patrick
Published in European journal of cancer (1990) (01.09.2009)
Published in European journal of cancer (1990) (01.09.2009)
Get full text
Journal Article